Introduced

Passed House

Passed Senate

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · February 14, 2025

To Health Services (H)

Introduced February 12, 2025

House

Adjourned Sine Die

2025 Regular Session

HB469

AN ACT relating to human gene therapy products and declaring an emergency.

Create a new section of KRS Chapter 214 to establish legislative intent; define terms; establish that a person in the Commonwealth shall not administer, by any route or modality, any human gene therapy product for any infectious disease indication, regardless of whether the administration is termed an immunization, vaccine, or any other term; exempt human gene therapy products used to treat cancer or genetic disorders; sunset the provisions on July 1, 2035, unless extended by the General Assembly; EMERGENCY.

Diseases Effective Dates, Emergency Health and Medical Services Pharmacists Physicians and Practitioners Public Health Sunset Legislation

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill would prohibit administering human gene therapy products intended to prevent infectious diseases in Kentucky, regardless of what they are called, including products labeled as vaccines or immunizations. It makes exceptions for gene therapy used to treat cancer or genetic disorders. The ban would expire on July 1, 2035, unless the state legislature votes to extend it. Who it may affect: Kentuckians seeking vaccines or immunizations for infectious diseases, healthcare providers who administer them, and public health agencies.

Open official bill text (PDF)·Report a problem with the summary